Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Advanced Gastric Cancer
Phase 2
21
about 9 months
18+
1 site in IL
What this study is about
Researchers are testing whether HIPEC, a treatment involving chemotherapy delivered directly into the abdomen, can be used more often than standard chemotherapy to improve outcomes in people with advanced gastric cancer that has spread to the lining of the abdominal cavity. The trial will last approximately 265 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Cisplatin
- 2.Take Mitomycin
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
cisplatin (Platinum chemotherapy; crosslinks DNA to stop replication), mitomycin
injection, intravenous, injection (Injection)
Primary: The PD-L1 expression can be upregulated after administration of HIPEC with greater frequency
Secondary: Overall Survival Rate